GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » China Biotech Services Holdings Ltd (HKSE:08037) » Definitions » 5-Year Yield-on-Cost %

China Biotech Services Holdings (HKSE:08037) 5-Year Yield-on-Cost % : 3.03 (As of Jun. 06, 2024)


View and export this data going back to 2004. Start your Free Trial

What is China Biotech Services Holdings 5-Year Yield-on-Cost %?

China Biotech Services Holdings's yield on cost for the quarter that ended in Dec. 2023 was 3.03.


The historical rank and industry rank for China Biotech Services Holdings's 5-Year Yield-on-Cost % or its related term are showing as below:

HKSE:08037' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.14   Med: 1.64   Max: 3.77
Current: 3.03


During the past 13 years, China Biotech Services Holdings's highest Yield on Cost was 3.77. The lowest was 1.14. And the median was 1.64.


HKSE:08037's 5-Year Yield-on-Cost % is ranked better than
63.77% of 69 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.33 vs HKSE:08037: 3.03

Competitive Comparison of China Biotech Services Holdings's 5-Year Yield-on-Cost %

For the Diagnostics & Research subindustry, China Biotech Services Holdings's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Biotech Services Holdings's 5-Year Yield-on-Cost % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, China Biotech Services Holdings's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where China Biotech Services Holdings's 5-Year Yield-on-Cost % falls into.



China Biotech Services Holdings 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of China Biotech Services Holdings is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

China Biotech Services Holdings  (HKSE:08037) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


China Biotech Services Holdings 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of China Biotech Services Holdings's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


China Biotech Services Holdings (HKSE:08037) Business Description

Traded in Other Exchanges
N/A
Address
255-257 Gloucester Roaad, Suites 1904-05A, 19th Floor, Sino Plaza, Causeway Bay, Hong Kong, HKG
China Biotech Services Holdings Ltd is an investment holding company. It operates through six segments: Pharmaceutical Products, Medical and Health-Related Services, Immunotherapy, Securities, Insurance brokerage, BNCT and Others. It derives prime revenue from the Medical and health related services segment which involves the provision of medical laboratory testing and health check services. The group has a business presence in Hong Kong and the PRC, of which key revenue is generated from Hong Kong.
Executives
Liu Xiaolin 2101 Beneficial owner
Genius Earn Limited 2201 Interest of corporation controlled by you
Genius Lead Limited 2101 Beneficial owner
Guoyuan International Holdings Limited 2201 Interest of corporation controlled by you
Guoyuan Securities Co., Ltd. 2201 Interest of corporation controlled by you
Guoyuan Securities Investment (hong Kong) Limited 2101 Beneficial owner
Richlane Ventures Limited 2101 Beneficial owner
Ko Chun Shun, Johnson 2201 Interest of corporation controlled by you

China Biotech Services Holdings (HKSE:08037) Headlines

No Headlines